HC9 Ventures closes $83 million first fund focused on healthcare software and services
HC9 focuses on early-stage investments in healthcare software and services businesses.
New York City-based HC9 Ventures has announced the closing of its first fund, an $83 million vehicle that will invest in healthcare software and services start-ups at seed and Series A stages.
As described in this news release, HC9 represents a significant evolution of the venture capital model, bringing true industry expertise to support portfolio companies through an engaged community of healthcare leaders. The firm was founded by longtime healthcare leaders and now fund General Partners Richard Lungen, Jon Gordon and Charlie Falcone.
Lungen and Falcone have a 16-year track record of unlocking revenue opportunities at scale and driving valuation growth through Leverage Health, the business development organization they previously founded. In the case of Gordon, he previously founded and led New York-Presbyterian’s corporate venture arm and is a multi-time entrepreneur and operator.
HC9 focuses on early-stage investments in healthcare software and services businesses, with an emphasis on companies that address care delivery or operational needs for payors and providers. Additionally, the team looks for founders who are seeking an engaged investor, businesses that have transformative potential, and opportunities where HC9 and its community can add meaningful value by drawing on its relationships and investor base to provide insights and introductions to drive meaningful inflections in the growth trajectories of these emerging businesses.
